Try a new search

Format these results:

Searched for:

in-biosketch:true

person:tanejs01

Total Results:

843


Re: organoid cultures derived from patients with advanced prostate cancer

Taneja, Samir S
PMID: 25890569
ISSN: 1527-3792
CID: 1542972

Re: are elderly patients with clinically localized prostate cancer overtreated? Exploring heterogeneity in survival effects

Taneja, Samir S
PMID: 25890513
ISSN: 1527-3792
CID: 1542962

Re: does discontinuous involvement of a prostatic needle biopsy core by adenocarcinoma correlate with a large tumor focus at radical prostatectomy?

Taneja, Samir S
PMID: 25890512
ISSN: 1527-3792
CID: 1542952

Patterns of Repeat Prostate Biopsy Utilization in Contemporary Clinical Practice

Abraham, Nitya E; Mendhiratta, Neil; Taneja, Samir S
PURPOSE: The objectives of this study were to: 1) describe the patterns of repeat prostate biopsy utilization in men with previous negative biopsy, and 2) identify predictors of prostate cancer (CaP) diagnosis in these men on repeat biopsy. MATERIALS & METHODS: 1,837 men who underwent prostate biopsy between January 1, 1995 - January 1, 2010 were identified from a university faculty group practice. Characteristics of repeat biopsy were examined including indication for biopsy, number of repeat biopsies performed, # of cores obtained, and total PSA prior to biopsy. Features of CaP diagnosed on repeat biopsy were examined including Gleason score (GS), # of positive cores, %tumor, and treatment choice. Multivariable logistic regression was utilized to identify predictors of CaP. RESULTS: Initial biopsy was negative in 1,213 men. In 255 men, 798 repeat biopsies were performed. 63 men were diagnosed with CaP, of whom 33 (52%) had age 70, biopsies including > 20 cores, and 4th repeat biopsy were associated with an elevated likelihood of CaP diagnosis. CONCLUSION: In men selected for multiple repeat biopsy, clinically significant cancer is found at each round of sampling. Given the continued likelihood of cancer detection, even by the fifth biopsy, early consideration of saturation or image-guided biopsy in the repeat biopsy population may be warranted.
PMID: 25444971
ISSN: 0022-5347
CID: 1370282

Whole-lesion apparent diffusion coefficient metrics as a marker of percentage Gleason 4 component within Gleason 7 prostate cancer at radical prostatectomy

Rosenkrantz, Andrew B; Triolo, Michael J; Melamed, Jonathan; Rusinek, Henry; Taneja, Samir S; Deng, Fang-Ming
PURPOSE: To retrospectively assess the utility of whole-lesion apparent diffusion coefficient (ADC) metrics in characterizing the Gleason 4 component of Gleason 7 prostate cancer (PCa) at radical prostatectomy. MATERIALS AND METHODS: Seventy patients underwent phased-array coil 3T-magnetic resonance imaging (MRI) before prostatectomy. A uropathologist mapped locations and Gleason 4 percentage (G4%) of Gleason 7 tumors. Two radiologists independently reviewed ADC maps, aware of tumor locations but not G4%, and placed a volume-of-interest (VOI) on all slices including each lesion on the ADC map to obtain whole-lesion mean ADC and ADC entropy. Entropy reflects textural variation and increases with greater macroscopic heterogeneity. Performance for characterizing Gleason 7 tumors was assessed with mixed-model analysis of variance (ANOVA) and logistic regression. RESULTS: Among 84 Gleason 7 tumors (G4% 5%-85%, median 30%; 59 Gleason 3+4, 25 Gleason 4+3), ADC entropy was significantly higher in Gleason 4+3 than Gleason 3+4 tumors (R1: 5.27 +/- 0.61 vs. 4.62 +/- 0.78, P = 0.001; R2: 5.91 +/- 0.32 vs. 5.57 +/- 0.56, P = 0.004); mean ADC was not significantly different between these groups (R1: 0.90 +/- 0.15*10-3 cm2 /s vs. 0.98 +/- 0.21*10-3 cm2 /s, P = 0.075; R2: 1.06 +/- 0.19*10-3 cm2 /s vs. 1.14 +/- 0.16*10-3 cm2 /s, P = 0.083). The area under the receiver operating characteristic (ROC) curve (AUC) for differentiating groups was significantly higher with ADC entropy than mean ADC for one observer (R1: 0.74 vs. 0.57, P = 0.027; R2: 0.69 vs. 0.61, P = 0.329). For R1, correlation with G4% was moderate for ADC entropy (r = 0.45) and weak for mean ADC (r = -0.25). For R2, correlation with G4% was moderate for ADC entropy (r = 0.41) and mean ADC (r = -0.32). For both readers, ADC entropy (P = 0.028-0.003), but not mean ADC (P = 0.384-0.854), was a significant independent predictor of G4%. CONCLUSION: Whole-lesion ADC entropy outperformed mean ADC in characterizing Gleason 7 tumors and may help refine prognosis for this heterogeneous PCa subset. J. Magn. Reson. Imaging 2014. (c) 2014 Wiley Periodicals, Inc.
PMCID:4696491
PMID: 24616064
ISSN: 1053-1807
CID: 918092

T2-weighted imaging of the prostate: Impact of the BLADE technique on image quality and tumor assessment

Rosenkrantz, Andrew B; Bennett, Genevieve L; Doshi, Ankur; Deng, Fang-Ming; Babb, James S; Taneja, Samir S
PURPOSE: To retrospectively compare standard and BLADE T2-weighted imaging (T2WI) sequences of the prostate in terms of image quality and tumor assessment. METHODS: 49 prostate cancer patients (64 +/- 6 years) who underwent 3 T phased-array coil MRI before prostatectomy were included. T2WI was acquired using standard rectilinear and BLADE techniques. Two readers (R1, R2) independently localized the dominant lesion using T2WI alone and using multi-parametric imaging; recorded presence of extraprostatic extension (EPE) in each lobe; and scored lesion conspicuity and absence of motion artifact (1-5 scale; 5 = highest quality). A third reader, unblinded to pathology, placed ROIs to record tumor-to-peripheral-zone contrast. Standard and BLADE T2WI were compared using paired Wilcoxon tests. RESULTS: BLADE showed a trend toward improved motion artifact for R1 (3.4 +/- 1.3 vs. 2.9 +/- 1.5; p = 0.054) but not R2 (4.0 +/- 1.0 vs. 3.9 +/- 1.1; p = 0.880). Dominant lesions showed significantly lower conspicuity using BLADE for R1 (2.8 +/- 2.0 vs. 3.2 +/- 2.0; p = 0.011) but not R2 (2.3 +/- 1.6 vs. 2.4 +/- 1.7; p = 0.353), and significantly lower tumor-to-peripheral-zone contrast using BLADE (0.35 +/- 0.13 vs. 0.42 +/- 0.15; p
PMID: 25156471
ISSN: 0942-8925
CID: 1162262

Transition zone prostate cancer: revisiting the role of multiparametric MRI at 3 T

Rosenkrantz, Andrew B; Kim, Sooah; Campbell, Naomi; Gaing, Byron; Deng, Fang-Ming; Taneja, Samir S
OBJECTIVE. The purpose of this study was to retrospectively evaluate the impact of multiparametric prostate MRI, including diffusion-weighted imaging (DWI) performed using different b values as well as dynamic contrast-enhanced MRI (DCE-MRI) on the accuracy, sensitivity, and specificity for transition zone (TZ) tumor detection and localization. MATERIALS AND METHODS. We included 106 prostate cancer patients (mean age [+/- SD], 62 +/- 7 years) who underwent 3-T MRI with a pelvic phased-array coil before radical prostatectomy. Three radiologists independently reviewed cases to record the likelihood of tumor in each of six TZ regions. Scores were initially assigned using T2-weighted imaging alone, reassigned after integration of DWI at b = 1000 s/mm(2) and corresponding apparent diffusion coefficient (ADC) maps, reassigned again after integration of DWI at b = 2000 s/mm(2), and reassigned a final time after integration of DCE-MRI. Generalized estimating equations based on binary logistic regression were used to compare sessions for TZ tumor detection, using prostatectomy findings as reference standard. RESULTS. Of the TZ sextants, 9.7% (62/636) contained tumor. All readers had higher sensitivity for T2-weighted imaging integrated with DWI at b = 1000 s/mm(2) and ADC compared with T2-weighted imaging alone (reader 1, 54.8% vs 33.9%; reader 2, 53.2% vs 22.6%; and reader 3, 50.0% vs 19.4% [p /= 0.054). Other measures were similar across the four sessions (reader 1, specificity 97.4-98.3% and accuracy 91.2-95.9%; reader 2, specificity 95.8-98.4% and accuracy 91.0-92.6%; reader 3, specificity 90.9-96.7% and accuracy 88.1-89.2%). CONCLUSION. DWI assists TZ tumor detection through higher sensitivity, particularly when using a very high b value; DCE-MRI lacks further additional benefit.
PMID: 25714311
ISSN: 0361-803x
CID: 1473862

Re: Effect of Radium-223 Dichloride on Symptomatic Skeletal Events in Patients with Castration-Resistant Prostate Cancer and Bone Metastases: Results from a Phase 3, Double-Blind, Randomised Trial

Taneja, Samir S
PMID: 25765385
ISSN: 0022-5347
CID: 1495092

Re: Prospective Randomized Phase 2 Trial of Intensity Modulated Radiation Therapy with or without Oncolytic Adenovirus-Mediated Cytotoxic Gene Therapy in Intermediate-Risk Prostate Cancer

Taneja, Samir S
PMID: 25765386
ISSN: 0022-5347
CID: 1495102

Re: Ipilimumab versus Placebo after Radiotherapy in Patients with Metastatic Castration-Resistant Prostate Cancer that had Progressed after Docetaxel Chemotherapy (CA184-043): A Multicentre, Randomised, Double-Blind, Phase 3 Trial

Taneja, Samir S
PMID: 25765387
ISSN: 0022-5347
CID: 1495112